Skip to content

Effects of Active and PRT on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fascitis

Comparative Effects of Active and Positional Release Technique on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fasciitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06131762
Enrollment
26
Registered
2023-11-14
Start date
2023-02-20
Completion date
2024-02-20
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait, Pain, Plantar Fascitis

Keywords

pain, functions

Brief summary

The study is randomized and single -blinded. Ethical approval is taken from ethical committee of Riphah International university Lahore.Participants who will meet criteria will be requested to give verbal consent and to sign written consent form. After signing consent form participants will be allocated to the group A and Group B by using computerized generated randomization. Group A will receive ultrasound then Active release technique while group B will receive ultrasound and Positional release technique for 4 weeks. Treatment sessions will be 12 sessions, 3 sessions per week on alternative days for 4 weeks

Detailed description

A single blinded randomized clinical trial will be conducted on 26 subjects diagnosed for planter fasciitis from Jawad Club Faisalabad and Alfatah Sports Club, Faisalabad by looking for symptoms and tenderness at heel as mentioned in inclusion criteria and will confirmed by windlass test. Participants who will meet criteria will be requested to give verbal consent and to sign written consent form. After signing consent form participants will be allocated to the group A and Group B by using computerized generated randomization. Group A will receive ultrasound then Active release technique while group B will receive ultrasound and Positional release technique for 4 weeks. Treatment sessions will be 12 sessions, 3 sessions per week on alternative days for 4 weeks. Pain will be measured by Numerical Pain Rating Scale (NPRS), Foot and ankle disability will be assessed by Foot Function Index (FFI), while gait parameters i.e. walking speed will be measured by 4-meter walking test, and step and stride length will be evaluated by measuring tape by taking foot prints before and after the 4 weeks of treatment period. Data will be analyzed through statistical package for the social sciences (SPSS) version 22.

Interventions

OTHERActive release technique

This include active release technique for 4 weeks

This include positional release technique for 4 weeks

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

the assessor who will take the reading is blind

Intervention model description

Randomized control trail

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male runners age between 18-30 years * Duration of running at least 6 months * Positive windlass test * Patients with unilateral or bilateral plantar fasciitis

Exclusion criteria

* Recent accidental foot or ankle injury * Previous lower-body surgical intervention within 6 months * Recent fractures in the lower limb (femur, tibia, fibula or foot bones) within 6 months * Diagnosed musculoskeletal disorders (rheumatoid arthritis, calcaneal spurs) * Diagnosed neuropathy, local and systemic neurologic disorders (including sciatica, tarsal tunnel syndrome, nerve entrapment of abductor digiti minimi and posterior tibial

Design outcomes

Primary

MeasureTime frameDescription
Gait parameterspre and 4 weeks post interventiongait parameters will be measured by 4-meter walking test
Foot Functionpre and 4 weeks post interventionFoot function will be assessed by Foot Function Index (FFI),

Countries

Pakistan

Contacts

Primary ContactMalia younas, Ms DPT
maliayounas62@gmail.com03258292286

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026